CompletedNot Applicable

Biobank for African American Prostate Cancer Research in Florida

United States592 participantsStarted 2017-03-22

Plain-language summary

The purposes of this study are: a) to develop a statewide Biobank for prostate cancer among men of African Ancestry in Florida and; b) to examine whether smoking increases the aggressiveness of prostate cancer using several biological approaches. Investigators plan to contact African American prostate cancer patients regarding participation. This project has 3 main components. Eligible patients may choose to participate in any or all parts of the study: Questionnaires; Saliva Samples; Tumor Tissue.

Who can participate

Age range20 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The initial recruitment of cases will be done with 3 mailings: the first to introduce the study to the participant from Florida Cancer Data System (FCDS) of the Florida Department of Health and ask them to complete the eligibility form and contact information update form; a second mailing to those who are determined to be eligible for the study to obtain the Informed Consent Form and the Baseline survey; and a third mailing to those who completed the survey to obtain a saliva sample and medical release form for tissue. * Histologically biopsy confirmed, primary prostate cancer, diagnosed between January 2013 and December 2015 * African American or Black; Hispanic Black; Afro-Caribbean * Are at least 20 years old * Are a resident of Florida * Additional criteria may apply Exclusion Criteria: * Does not meet Inclusion Criteria

What they're measuring

Number of Complete Patient Data Records Collected at Three Years

Timeframe: Up to 3 years

Trial details

NCT IDNCT03232411

SponsorH. Lee Moffitt Cancer Center and Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-30